Somatostatin analogs therapy in gastroenteropancreatic neuroendocrine tumors: current aspects and new perspectives.
about
Somatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm, and octreotide long-acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumors.Somatostatin receptors in gastrointestinal stromal tumors: new prognostic biomarker and potential therapeutic strategymRNA expression of somatostatin receptor subtypes SSTR-2, SSTR-3, and SSTR-5 and its significance in pancreatic cancer.AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas.ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor CellsEffects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study.Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.Subgroup analysis of patients with G2 gastroenteropancreatic neuroendocrine tumors.Radiotheranostics in Cancer Diagnosis and Management.Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms.Clinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors.Molecular challenges of neuroendocrine tumors.Carcinoid-syndrome: recent advances, current status and controversies.
P2860
Q33598860-AA2F9DC2-C37A-433A-A132-2C5D67CFBA9DQ34978826-A99DFEBA-E4A1-43BC-B880-8FB1956BC81BQ35084849-BA37EBF9-CD78-4792-B9F1-3C925E95302CQ36659064-AA36E7E3-45A7-401E-9ADF-BC8610385EA1Q36849357-EBF4964C-B88E-472F-9345-8B336C54DCEAQ37611641-4C02E9A6-D9A2-4367-A682-1EC213A7CEA3Q38743093-A2CF1973-477E-4511-8334-CAD7F86067C5Q38956091-5A8DC7AA-3771-47E8-937F-7AD29698FE7BQ40773502-CCB9F263-5316-4168-A984-1C146E777B2BQ47719762-64BED6B9-6986-4025-8204-7BBE51764477Q47724538-67EF3EAF-6681-4AE7-AD96-7763822556C6Q49352143-31CE563C-B6C9-43C0-9158-391E63C7803FQ49875027-EC793409-B5AC-4ECC-9862-C9E5C8938021Q50094023-20422DF6-C50F-4908-8899-BB2C9AC81ADA
P2860
Somatostatin analogs therapy in gastroenteropancreatic neuroendocrine tumors: current aspects and new perspectives.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Somatostatin analogs therapy i ...... aspects and new perspectives.
@en
Somatostatin analogs therapy i ...... aspects and new perspectives.
@nl
type
label
Somatostatin analogs therapy i ...... aspects and new perspectives.
@en
Somatostatin analogs therapy i ...... aspects and new perspectives.
@nl
prefLabel
Somatostatin analogs therapy i ...... aspects and new perspectives.
@en
Somatostatin analogs therapy i ...... aspects and new perspectives.
@nl
P2093
P2860
P50
P356
P1476
Somatostatin analogs therapy i ...... aspects and new perspectives.
@en
P2093
P Di Giacinto
Roberto Baldelli
S M Corsello
P2860
P356
10.3389/FENDO.2014.00007
P577
2014-02-07T00:00:00Z